Insight Molecular Diagnostics (IMDX) Long-Term Deferred Tax (2018 - 2019)

Insight Molecular Diagnostics has disclosed Long-Term Deferred Tax across 2 years of filings, most recently posting $3.8 million for Q4 2019.

• Long-Term Deferred Tax for Q4 2019 came in at $3.8 million, down 43.51% year-over-year; the trailing twelve-month figure through Dec 2019 was $3.8 million (down 43.51% YoY), and the FY2019 annual result was $3.8 million, down 43.51% from the prior year.
• Long-Term Deferred Tax came in at $3.8 million for Q4 2019 at Insight Molecular Diagnostics, down from $6.8 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $6.8 million in Q4 2018 to a low of $3.8 million in Q4 2019.